XML 72 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity - Summary of Stock Option Activity (Detail)
$ / shares in Units, $ in Millions
9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Weighted Average Remaining Contractual Life in Years 7 years 9 months 18 days
Weighted Average Remaining Contractual Life in Years, options exercisable at September 30, 2022 7 years 3 months 18 days
Weighted Average Remaining Contractual Life in Years, options unvested and expected to vest at September 30, 2022 8 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding, beginning balance | shares 500,000.0
Options granted | shares 176,200
Options outstanding, ending balance | shares 676,200
Options exercisable at September 30, 2022 | shares 415,000.0
Options unvested and expected to vest at September 30, 2022 | shares 242,200
Weighted-average grant date fair value  
Weighted-average grant date fair value, options beginning balance | $ / shares $ 39.26
Weighted-average grant date fair value, options granted | $ / shares 45.05
Weighted-average grant date fair value, options ending balance | $ / shares 40.77
Weighted-average grant date fair value, options exercisable at September 30, 2022 | $ / shares 37.53
Weighted-average grant date fair value, options unvested and expected to vest at September 30, 2022 | $ / shares $ 45.86
Aggregate Intrinsic Value, options outstanding | $ $ 0.5
Aggregate Intrinsic Value, options exercisable at September 30, 2022 | $ 0.5
Aggregate Intrinsic Value, options unvested and expected to vest at September 30, 2022 | $ $ 0.1